Deciphera Pharmaceuticals
Deciphera is seeking an experienced Territory Manager to lead the launch of tirabrutinib for patients with relapsed or refractory primary central nervous system lymphoma. The role involves developing strategic business plans, building relationships with hematology/oncology professionals, and communicating clinical data to drive treatment adoption. This field-based position requires residing within the assigned Florida and Georgia territory to effectively support customer coverage and travel needs.
Headquarters
Waltham, Massachusetts, United States
Company Size
201-500 employees
Founded
2003
Deciphera Pharmaceuticals, now a member of ONO Pharma, is a biopharmaceutical company dedicated to discovering, developing, and commercializing switch-control kinase inhibitors and other targeted therapies to improve outcomes for people with cancer. The company's portfolio includes approved medicines QINLOCK (ripretinib) for advanced gastrointestinal stromal tumor and ROMVIMZA (vimseltinib), as well as a broad pipeline of clinical-stage candidates such as tirabrutinib and sapablursen. Driven by a patient-inspired mission to defeat cancer, Deciphera focuses on addressing key mechanisms of tumor and drug resistance through its proprietary discovery platform.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Deciphera Pharmaceuticals.
76% above the average for this role
Senior Therapeutic Area Specialist - Oncology/Hematology- Tampa, FL
Bristol Myers Squibb
Faculty Member - Malignant Hematology
Mct Hiring
Hematology/Oncology
HealthPlus Staffing
Faculty Position in Hematology and Oncology
The University of Alabama at Birmingham
Faculty Position in Hematology and Oncology
The University of Alabama at Birmingham
Board-Certified or Board-Eligible Hematology & Oncology Physician
The Oncology Institute